| Pharmaceutical active ingredients: |
| ChlorthalidoneMetoprolol Tartrate |
| Available forms, composition and doses of Igroton-Lopresor: |
| N / A |
| Igroton-Lopresor medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C07BB02 - Metoprolol and thiazides |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Trepress | Chlorthalidone; Hydralazine Hydrochloride; Oxprenolol Hydrochloride | Novartis; Azupharma; Sandoz |
| Biotens | Chlorthalidone; Labetalol Hydrochloride | Kemyos Biomedical Research |
| Diurolab | Chlorthalidone; Labetalol Hydrochloride | Leben's |
| Pressalolo Diuretico | Chlorthalidone; Labetalol Hydrochloride | Locatelli Farmaceutici |
| Trandiur | Chlorthalidone; Labetalol Hydrochloride | Teofarma |
| Logroton | Chlorthalidone; Metoprolol Tartrate | Novartis; Recipe, Austria; Sankyo |
| Logroton Divitabs | Chlorthalidone; Metoprolol Tartrate | Novartis; Zuellig Pharma |
| Logroton Retard | Chlorthalidone; Metoprolol Tartrate | Novartis; Zuellig Pharma |
| Lopresoretic | Chlorthalidone; Metoprolol Tartrate | Novartis |
| Lopressidone | Chlorthalidone; Metoprolol Tartrate | Novartis |